Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2021-01-26

FDA Approved: DELFLEX — Supplemental Application (Fresenius Medical Care North America)

View source ↗

Summary

The FDA approved a supplemental application for DELFLEX, a dialysis solution from Fresenius Medical Care North America, to update its formulation (dextrose mono…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • DELFLEX (DEXTROSE MONOHYDRATE, SODIUM CHLORIDE, SODIUM LACTATE, CALCIUM CHLORIDE, MAGNESIUM CHLORIDE)

Snippet

SUPPL AP for DELFLEX (DEXTROSE MONOHYDRATE, SODIUM CHLORIDE, SODIUM LACTATE, CALCIUM CHLORIDE, MAGNESIUM CHLORIDE)